First-time generic drug approvals, April 2008

Generic drugs approved by FDA (through April 2008) including cefuroxime for oral suspension, pramipexole tablets, alendronate once-daily tablets, and alendronate once-weekly tablets.

Cefuroxime for oral suspension, 125 and 250 mg/5 mL (equiv to Ceftin for oral suspension)

RANBAXY

Pramipexole tablets, 0.125, 0.25, 0.5, 1, and 1.5 mg (equiv to Mirapex tablets)

Alendronate once-daily tablets, 5, 10, and 40 mg, and once-weekly tablets, 35 mg (equiv to Fosamax tablets)

TEVA

Alendronate once-weekly tablets, 70 mg (equiv to Fosamax tablets)

TEVA, BARR